ArticleAging and disease2020
COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?
Article in Aging and disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The role of children in household transmission of COVID-19: a systematic review and meta-analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022Pooled it
- Investigation of Risk Factors for Hospitalization of COVID-19 Patients with Diabetes in Najaf, Iraq.Archives of Razi Institute · 2022Article
- RdRp (RNA-dependent RNA polymerase): A key target providing anti-virals for the management of various viral diseases.Journal of molecular structure · 2022Review
- Geographical Appraisal of COVID-19 in West Bengal, India.GeoJournal · 2022Article
- SARS-CoV-2 infection in India bucks the trend: Trained innate immunity?American journal of human biology : the official journal of the Human Biology Council · 2021Article
- Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits.Expert review of anti-infective therapy · 2021Review
- Influence of Population Density for COVID-19 Spread in Malaysia: An Ecological Study.International journal of environmental research and public health · 2021Article
- Declining Mortality Rate of Hospitalised Patients in the Second Wave of the COVID-19 Epidemics in Italy: Risk Factors and the Age-Specific Patterns.Life (Basel, Switzerland) · 2021Article
- Environmental perspective of COVID-19: Atmospheric and wastewater environment in relation to pandemic.Ecotoxicology and environmental safety · 2021Review
- Cross-immunity and trained immunity in explaining variable COVID-19 mortality-Guidance for future pandemics.Journal of medical virology · 2021Article
- Spatio-temporal variations in COVID-19 in relation to the global climate distribution and fluctuations.Spatial and spatio-temporal epidemiology · 2021Article
- Coronavirus Disease (COVID-19): A Perspective from Immunosenescence.Aging and disease · 2021Article
- Older age groups and country-specific case fatality rates of COVID-19 in Europe, USA and Canada.Infection · 2021Article
- Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension.Stem cell reviews and reports · 2021Review
- Circulating levels of IL-2, IL-4, TNF-α, IFN-γ, and C-reactive protein are not associated with severity of COVID-19 symptoms.Journal of medical virology · 2021Article
- Renin-angiotensin-aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis.Therapeutic advances in drug safety · 2021Article
- Genetic Drift Versus Climate Region Spreading Dynamics of COVID-19.Frontiers in genetics · 2021Article
- Of Cross-immunity, Herd Immunity and Country-specific Plans: Experiences from COVID-19 in India.Aging and disease · 2020Article
- Repurposing of SARS-CoV nucleocapsid protein specific nuclease resistant RNA aptamer for therapeutics against SARS-CoV-2.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2020Article
- Clinical features and risk factors for ICU admission in COVID-19 patients with cardiovascular diseases.Aging and disease · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ongoing Corona virus (COVID-19) pandemic has witnessed global political responses of unimaginable proportions. Many nations have implemented lockdowns that involve mandating citizens not to leave their residences for non-essential work. The Indian government has taken appropriate and commendable steps to curtail the community spread of COVID-19. While this may be extremely beneficial, this perspective discusses the other reasons why COVID-19 may have a lesser impact on India. We analyze the current pattern of SARS-CoV-2 transmission, testing, and mortality in India with an emphasis on the importance of mortality as a marker of the clinical relevance of COVID-19 disease. We also analyze the environmental and biological factors which may lessen the impact of COVID-19 in India. The importance of cross-immunity, innate immune responses, ACE polymorphism, and viral genetic mutations are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.